Topic: GILEAD
33 results were found.
Gilead Sciences to acquire CymaBay for $4.3 billion - February 13, 2024
New Mexico: Lawsuit filled against Gilead, Bristol-Myers Squibb, Teva in HIV/AIDS drugs case - March 4, 2021
Gilead Sciences will create 275 jobs in the Research Triangle Region - February 12, 2021
WHO advises doctors not to use Gilead’s remdesivir for coronavirus - November 20, 2020
Mexico will not follow FDA in approving Gilead's coronavirus drug - October 24, 2020
Gilead Sciences to sell 500,000 doses of remdesivir to Europe - October 9, 2020
Gilead to pay $97 million to resolve alleged false claims act liability for paying kickbacks - September 24, 2020
Gilead Sciences to acquire Immunomedics for approximately $21 billion - September 14, 2020
Gilead says remdesivir coronavirus treatment reduces risk of death - July 10, 2020
Gilead's stock rallies, AstraZeneca falls after Gilead said not interested in merger - June 8, 2020
AstraZeneca in informal talks with Gilead Sciences for potential merger - June 8, 2020
Bad news: Gilead's coronavirus drug Remdesivir shows mixed results - June 1, 2020
Iranian hackers target Gilead Sciences, says report - May 11, 2020
Gilead Sciences sues U.S.: They secretly obtained patents on HIV research - April 27, 2020
Gilead Sciences appealed $778 million ruling, now will pay $1.2 billion - April 10, 2020
United States files complaint against Gilead for patent infringement - November 8, 2019
Gilead Sciences and Galapagos enter $5.05 billion, 10-year collaboration - July 14, 2019
Gilead is blocking drug that would save Brazil $275 million a year - September 12, 2018
Gilead Sciences appoints Harish M. Manwani to board - May 10, 2018
Gilead Sciences to buy Cell Design Labs for up to $567 million - December 8, 2017
Gilead Sciences to acquire Kite Pharma for $11.9 billion - August 28, 2017
Alessandro Riva to join Gilead as senior vice president - January 4, 2017
Gilead Sciences adds Kelly Kramer to board of directors - August 24, 2016
Gilead names Kevin Young COO - May 26, 2016
Gilead Sciences total revenues $7.8 billion - April 29, 2016
Gilead to pay up to $1.2 billion for Nimbus unit, drug candidate - April 5, 2016
Gilead Sciences to pay Merck $200 million for infringing two patents - March 25, 2016
Gilead Sciences appoints John C. Martin as executive chairman - February 1, 2016
Gilead Sciences buys EpiTherapeutics for $65 million - May 7, 2015
Amiad Water Systems appoinst Gilead Fortuna as director - March 30, 2015
Gilead Sciences: director Paul Berg to retire - November 6, 2010
Gilead Sciences: John G. McHutchisonnew senior vice president - June 9, 2010
Per Wold-Olsen joins Gilead Sciences' board - January 29, 2010